Article

International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?

Section of Environment and Radiation, International Agency for Research on Cancer (IARC), Lyon, France; Association of Dermatological Prevention (ADP) e.V., Hamburg, Germany; EUROSKIN e.V., Buxtehude, Germany. .
International Journal of Cancer (impact factor: 5.44). 04/2012; DOI:10.1002/ijc.27616
Source: PubMed

ABSTRACT The incidence of cutaneous malignant melanoma has steadily increased over the past 50 years in predominately fair-skinned populations. This increase is reported to have leveled off recently in several Northern and Western European countries, Australia, New Zealand and in North America. We studied the global patterns and time trends in incidence of melanoma by country and sex, with a focus on and age- and cohort-specific variations. We analyzed the incidence data from 39 population-based cancer registries, examining all-ages and age-truncated standardized incidence rates of melanoma, estimating the annual percentage change and incidence rate ratios from age-period-cohort models. Incidence rates of melanoma continue to rise in most European countries (primarily Southern and Eastern Europe), whereas in Australia, New Zealand, the U.S., Canada, Israel and Norway, rates have become rather stable in recent years. Indications of a stabilization or decreasing trend were observed mainly in the youngest age group (25-44 years). Rates have been rising steadily in generations born up to the end of the 1940s, followed by a stabilization or decline in rates for more recently born cohorts in Australia, New Zealand, the U.S., Canada and Norway. In addition to the birth cohort effect, there was a suggestion of a period-related influence on melanoma trends in certain populations. Although our findings provide support that primary and secondary prevention can halt and reverse the observed increasing burden of melanoma, they also indicate that those prevention measures require further endorsement in many countries.

0 0
 · 
0 Bookmarks
 · 
46 Views
  • Source
    Article: New landscape in the treatment of melanoma: a 2012 update
    [show abstract] [hide abstract]
    ABSTRACT: The possibilities in treating melanoma patients changed dramatically in the last few years. Several new immunotherapies and targeted therapies have demonstrated promising antitumor activity with manageable side effects in patients with advanced melanoma. These include ipilimumab and PD-1(L) antibodies, and the targeted agents vemurafenib (BRAF-inhi- bitor), dabrafenib (BRAF-inhibitor), and trametinib (MEK-inhibitor). Although early clinical trials have not indicated that any of these offers a “breakthrough” in terms of antitumor activity for all patients, each will likely offer incremental improvements over standard care. Complex immunotherapies with adoptive T-cell transfer after nonmyeloablative lymphodeple- tion suggest response rates that are extraordinary; however, these results were derived from highly selected patient cohorts in single centers only. In the adjuvant setting interferon-α is still considered standard of care for high-risk melanoma patients. However, improvement rates for overall survival are still low. Therefore, sufficient markers for selection of patients who will profit from interferon-α are urgently needed. New drugs such as ipilimumab and BRAF/MEK inhibitors are already in clinical trials in the adju- vant setting, and may probably improve the possibilities to treat patients being at high risk for recurrence in a few years.
    ONCOLOGIE 02/2013; · 0.12 Impact Factor

Keywords

39 population-based cancer registries
 
age-period-cohort models
 
age-truncated standardized incidence rates
 
annual percentage change
 
birth cohort effect
 
certain populations
 
cohort-specific variations
 
cutaneous malignant melanoma
 
European countries
 
global patterns
 
incidence rate ratios
 
Incidence rates
 
melanoma trends
 
New Zealand
 
period-related influence
 
predominately fair-skinned populations
 
Rates
 
time trends
 
Western European countries
 
youngest age group